Pharma & Bio
Technology
[Bio Spotlight] SkyLabs, Maker of 'Ring-Type Blood Pressure Monitor,' Rises Again… SAMIK PHARM. Co., LTD., Part of the Hair Loss Theme, Also Surges
On the 13th, the domestic pharmaceutical, biotech, and healthcare sectors saw strong buying momentum driven by a combination of expectations for explosive growth from newly listed medical device compa…
Lifestyle
LNP: Essential for mRNA… Who Will Capture the 4 Trillion Won Manufacturing Market? [A Close Contest in K-Bio]
Following the application of the messenger RNA (mRNA) concept to COVID-19 vaccines—which have already been commercialized—and the emergence of results from a completely new type of “cancer vaccine,” a…
Technology
Coreline Soft Co., Ltd. Sees German Contracts Surge Sevenfold… High Expectations for Second-Half Earnings
Coreline Soft Co., Ltd.(384470)has secured 77 new medical institutions in Germany through July of this year. Compared to last year, when new contracts totaled only about 10 for the entire year, this r…
Technology
Kolon TissueGene, Inc.: Key Clinical Staff Member Resigns from TG-C Project... Aftermath of Phase 3 Clinical Trial Failure?
Kolon TissueGene, Inc.(950160)has decided to replace key personnel responsible for its U.S. clinical and regulatory affairs, drawing attention to the reasons behind this move. This personnel change is…
Technology
"From 140 mg to 280 mg"... G2GBIO, Inc. Solves the Puzzle of Dosage for Monthly Dementia Injection
#G2GBIO, Inc. has obtained new data on repeated administration of a high 280 mg dose of GB-5001, a once-monthly long-acting donepezil injection. Following the results of the 140 mg repeated-dose domes…
Lifestyle
Wise birds Inc. Is the ‘Only Listed Advertising Company to Exceed a 20% Operating Profit Margin’… Making a Quantum Leap with U.S. DTC Biotech
As the shadow of the economic downturn deepens and the advertising market remains frozen solid, the AI-based ad tech company Wise birds Inc.(273060)has become the only publicly listed advertising firm…
Lifestyle
WSI Co., Ltd. Brings Medical Robotics and New Drug Industries into Focus… Setting Its Sights on the “100 Billion Club” by 2028
WSI Co., Ltd.(299170), a company specializing in pharmaceuticals and medical devices, is breaking away from its long-standing distribution-centric business model—which had been heavily reliant on a si…
Technology
CureStream Aims for ‘AI Pancreas Subscription’ Beyond Insulin Pumps… Targeting an IPO in 2028
CureStream, a developer of insulin pumps, has received approval for its AI-based, fully autonomous insulin delivery algorithm as an independent software medical device and is launching a subscription …
Business·Industry
[Noul Co., Ltd. Deep Seek ②] Mergers of Penny Stocks Are Not the End… 'Triple-Tiered Watch List Risk'
Noul Co., Ltd.(376930)Although the company is proceeding with a 5-to-1 stock consolidation following its designation as a “monitored stock” due to a share price below 1,000 won, the risk of delisting …
Lifestyle
Mezzion Pharma Co., Ltd. Launches Udenafil Clinical Trials in the U.K. Following Korea and the U.S. … Final Piece of the Puzzle in Place for Fontan Treatment Approval
Mezzion Pharma Co., Ltd.(140410)is expanding the scope of “FUEL-2,” the global Phase 3 clinical trial for udenafil—a drug under development for the treatment of Fontan patients—to the United Kingdom. …